Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Genetic and molecular diagnostic testing company announces financial results
June 2nd, 2005
NeoGenomics, Inc., (NGNM) announced its results for the 3 months ending March 31, 2005. Significant accomplishments during the quarter included the following: -69% increase in sequential revenues vs. Q4 FY 2004 -29% increase in year-over-year revenues vs. Q1 FY 2004 -Successful roll-out of two new laboratory platforms: flow cytometry and fluorescence insitu hybridization (FISH) -24% of cases ordering more than one test per case, resulting in a 24% increase in average revenue per case. -Additional $146,000 of equity raised during the quarter -Refinanced existing $740,000...
Source: Women's Health Weekly (2005-06-02)
|
